行业与政策媒体报道国际
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
今日摘要使用自己的 API，仅供个人查看
来源摘要
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
阅读原始来源- 来源
- TechCrunch AI · 媒体报道
- 来源发布
- 2026/09/24 03:31
- 首次采集
- 2026/09/24 05:59
本文为公开信息索引与摘要，详情及后续变化请以原始来源为准。